Molecure SA Sustainability Reports
Molecure S.A. is a clinical-stage biopharmaceutical company focused on discovering and developing small-molecule drugs for neoplastic and inflammatory diseases. The company uses medicinal chemistry and preclinical biology platforms to identify and target underexplored protein activities.
Sector: Professional & technical services
Country: Poland
Exchange: Warsaw Stock Exchange
LEI: 2594003L11V38ZCVKZ09
FIGI: BBG00K9D8Y04
2 reports from 2022 to 2024
